Clinical Trial Update: Tranexamic Acid in Cyanotic Heart Defects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating tranexamic acid for postoperative hemorrhage in patients with cyanotic heart defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Hemorrhage in Cyanotic Heart Defects

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Assiut University | Conditions: Postoperative Hemorrhage | Phase 2 | Status: COMPLETED